|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| C07H 21/02 |
| (11) | Number of the document | 2723758 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12802093.0 |
| Date of filing the European patent application | 2012-06-20 | |
| (97) | Date of publication of the European application | 2014-04-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/043378 |
| Date | 2012-06-20 |
| (87) | Number | WO 2012/177784 |
| Date | 2012-12-27 |
| (30) | Number | Date | Country code |
| 201161499620 P | 2011-06-21 | US | |
| 201261638288 P | 2012-04-25 | US |
| (72) |
BETTENCOURT, Brian, US
QUERBES, William, US
FITZGERALD, Kevin, US
FRANK-KAMENETSKY, Maria, US
MILSTEIN, Stuart, US
SHULGA-MORSKAYA, Svetlana, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSTIONS AND METHODS OF USE THEREOF |
| ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSTIONS AND METHODS OF USE THEREOF |